Unichem Laboratories gets USFDA gesture for Cyclobenzaprine HCI Tablets
- Post By : Kumar Jeetendra
- Source: Agencies
- Date: 08 Jul,2020
Unichem Laboratories has gotten ANDA endorsement for its Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, 7.5 mg and 10 mg from the United States Food and Drug Administration (USFDA) to showcase a nonexclusive rendition of FLEXERIL (Cyclobenzaprine HCI) Tablets, 5 mg and 10 mg of Janssen Research and Development LLC.
Cyclobenzaprine HCI Tablets are shown for the treatment as an extra to rest and active recuperation for alleviation of muscle fit related with intense, difficult musculoskeletal conditions.
The item will be marketed from Unichem’s Goa Plant.